Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Improving Health Outcomes With Kefir

for
Systemic Inflammatory Response, Diabetes Mellitus, Type 2,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 24 - 70

Code: NCT06695221

Recruiting

Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study

for
High Blood Sugar, High Blood Pressure, Overweight and Obesity
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 70

Code: NCT06555393

Phase 1, Recruiting

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

for
Intracerebral Hemorrhage, Stroke, Hypertension
Location: New York NY, Albany NY, Frederick MD, Stuart FL,
Sponsor: Zeenat Qureshi Stroke Institute

Sex: All

Age: 18 - 70+

Code: NCT06402968

Recruiting

Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic

for
Hypertension (HTN)
Location: Cleveland OH
Sponsor: Anita Misra-Hebert

Sex: All

Age: 18 - 70+

Code: NCT07232017

Recruiting

Phase I Human Analytics (HALO) Study

for
Cardiovascular Diseases, Cancer, Dementia,
Location: Indian Wells CA
Sponsor: HALO Diagnostics

Sex: Male

Age: 45 - 70+

Code: NCT05423860

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Penn Medicine Healthy Heart

for
Hypertension, Hyperlipidemias
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 35 - 70+

Code: NCT06062394

Recruiting

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

for
Stroke, Brain Disease, Vascular Diseases,
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT06615973

Recruiting

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

for
Hypertension
Location: Flint MI
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT06391073

Recruiting

PILI 'Āina Household

for
Type 2 Diabetes, Hypertension, Dyslipidemias,
Location: Honolulu HI, Kapolei HI
Sponsor: University of Hawaii

Sex: All

Age: 18+

Code: NCT06526273

Recruiting

The Impact of a Low or High Phosphate Diet on Phosphate and Calcium Excretion in Healthy People

for
Cardiovascular Diseases, Aging, Nutrient; Excess
Location: Kingston
Sponsor: Clinical Evaluation Research Unit at Kingston General Hospital

Sex: All

Age: 20 - 40

Code: NCT04013776

Recruiting

Healthy Heart Score Intervention In the Primary Care Setting

for
Cardiovascular Diseases
Location: Dublin OH
Sponsor: Ohio University

Sex: All

Age: 18+

Code: NCT03482427

Recruiting

Sympathetic Mechanisms in Obesity-Crossover Design

for
Obesity, Hypertension
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18 - 65

Code: NCT05312892

Phase 1, Phase 2, Recruiting

Mindfulness to Reduce Ambulatory Hypertension in Atrial Fibrillation

for
Atrial Fibrillation, Hypertension, Mindfulness,
Location: Newmarket
Sponsor: York University

Sex: All

Age: 50 - 70+

Code: NCT03910192

Recruiting

Aggressive Smoking Cessation Trial (ASAP)

for
Acute Coronary Syndrome, Cardiovascular Diseases
Location: Saint John's, Halifax, Moncton, Quebec City, Montreal,
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: All

Age: 18+

Code: NCT05257629

Phase 3, Recruiting

Semaglutide and Vascular Regeneration

for
Atherosclerosis, Cardiovascular Diseases,
Location: Scarborough, North York
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group

Sex: All

Age: 18+

Code: NCT05870462

Recruiting

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

for
Dyslipidemias, Cardiovascular Diseases, HIV Infections,
Location: Houston TX, Los Angeles CA, San Francisco CA
Sponsor: Priscilla Hsue, MD

Sex: All

Age: 40+

Code: NCT05488431

Phase 2, Recruiting

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

for
In-Stent Restenosis, Cardiovascular Diseases,
Location: New Haven CT, Bronx NY, New York NY, New York City NY,
Sponsor: Concept Medical Inc.

Sex: All

Age: 18 - 70+

Code: NCT05908331

Recruiting

Prevention of Progression of Prediabetes, Obesity and CV Risk

for
Pre-Diabetes, Weight, Body, Cardiovascular Diseases
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18+

Code: NCT06446531

Phase 1, Recruiting

COVID-19 Longitudinal Biomarkers in Lung Injury

for
Covid19, Respiratory Disease, Critical Illness
Location: Toronto
Sponsor: Dr. Andrew Baker

Sex: All

Age: 18+

Code: NCT04747782

Recruiting

Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention

for
Cardiovascular Diseases, Metabolic Syndrome
Location: Loveland CO
Sponsor: Poudre Valley Health System

Sex: All

Age: 13+

Code: NCT05322876

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial